ABSTRACT
INTRODUCTION
Nearly one million new cases of gastric malignancy most commonly diagnosed cancer in the world. 1 Gastric malignancy itself remains a global killer being the world's third commonest cause of death from malignant disease. 1, 2 Global Burden of Cancer Study (GLOBOCAN) estimates that 723,000 cancer related deaths occurred worldwide in 2012 were caused by gastric malignancy. 1 More than 70% of the world's new cases occur in developing countries, and half of the world total occurs in Asia. World Health Organization South-East Asia Region (WHO SEARO) recorded 91,000 new cases of gastric cancer in 2012, 6,000 (6.6%) of them were from Indonesia. Although the incidence of gastric cancer in Indonesia is very low, gastric cancer may resulted in 5,400 deaths in 2012. 1 Due to high rate of mortality, accurate diagnostic study is necessary in order to establish early diagnosis.
Endoscopy has facilitated early diagnosis of patients with upper gastrointestinal (UGI) malignancy and provided modalities in obtaining samples for histological diagnosis of gastric cancer. 3 It has widely known that the endoscopic appearances highly suggestive but not pathognomonic and needs further detection of gastric cancer are varied among studies, ranging from 86-97.4%. 4, 5 For the distinction between malignant and non-malignant lesion, histological evaluation remains the gold standard. 6 Therefore, we aim to determine the prevalence of gastric malignancy and diagnostic value of UGI endoscopy in detection of gastric malignancy in Sanglah Hospital, Denpasar.
METHOD
This is a retrospective analytical study of UGI endoscopy conducted on patients in Endoscopy Unit of Sanglah Hospital Denpasar between January 2012 and December 2014. Inclusion criteria were all patients with dyspepsia, heartburn, or history of gastrointestinal bleeding. Exclusion criteria were patients under 17 years old and patients with documented chronic liver disease.
Endoscopy was done by using flexible video endoscope (Olympus Exera II GF-170). On endoscopy, gastrointestinal lesions were visualized. Details of the site, extent, and type of the lesion were recorded. After visualization of the lesion, biopsies were retrieved by using forceps. Two biopsies were taken for non-malignant lesion, and 6 biopsies for malignant lesion. Biopsies were transferred to a container bottle containing 10% formalin buffer, labelled with patient's identity, immediately after the biopsies were obtained. Biopsy tissues then processed and cut by using microtome until 4-5 series of slides were resulted. Slides were stained routinely with Giemsa. The histopathological interpretations were derived according to WHO classification. 6 Biopsies were interpreted as negative and positive for malignancy. Malignant lesion were interpreted as a well-demarcated lesion and irregularity in color/surface pattern.
with nodular looking folds and irregular overhanging, nodular margin.
SPSS 17 was used in statistical analysis of this study. Age was summarized as mean and standard deviation (SD). Sex was presented as counts and percentages. Using histological examination as the gold standard for diagnosis of gastric malignancy, we value (PPV), negative predictive value (NPV), and accuracy by generating 2 x 2 tables.
RESULTS
Between January 2012 and December 2014,1478 underwent UGI endoscopy. Three hundred and ten patients were excluded because of documented chronic liver disease or had age less than 17 years old. One thousand and sixty eight patients were included in this study. Mean age of patients was 51.24 ± 15.14 years. There were 614 (57.49%) males and 454 (42.51%) females. Thirty nine (39) out of 1068 patients with endoscopically proven gastric malignancy were were positive for malignancy in 29 (2.72%) cases and negative in 10 cases. Majority of the lesions were found in the antrum (51.28%), 14 (35.9%) in the body, 2 (5.13%) in the cardia, and 3 (7.69%) were diffuse. A histological diagnosis of gastric cancer was established in 29 (74.36%) patients. In 10 (25.64%) patients the histology was negative for malignancy (Table 1, Figure  1 ). Eighteen out of 29 (62%) patients were less than 55 years old (Figure 2) .
Out of the 39 cases diagnosed as probable gastric malignancy endoscopically, 29 were found to be malignant and 10 were negative for malignancy (Table   and negative 
DISCUSSION
Although the prevalence of gastric cancer has been declining over several decades, it still represents major health problem. 1 By knowing the prevalence, physician may build awareness towards gastric cancer. In this histopathological study was 2.72%. Among patients in Western Countries who had endoscopic evaluations, gastric carcinoma were found in 1-2% of cases. 7 However, this number is higher in Asia. Study in Cipto Mangunkusumo hospital showed prevalence of 2.98%. 8 Malignancy was noted in 3.5% of the total 3,432 patients performing endoscopy in India. 9 Study in East Asian Countries showed more dramatic results, This study also showed that 62% of gastric cancer patients were < 55 years old. The increased frequency of gastric cancer patients younger than traditional cutoff for alarm signs showed that increased surveillance on younger age group need to be taken. Study in Jakarta from 2007-2011 showed that there was shifting toward health awareness of patients, increased number of endoscopists and endoscopic facilities in Indonesia. 11 Macroscopic appearance in endoscopy has shown high probability of gastric malignancy. However, there has been few reports of studies questioning the accuracy of endoscopy. 4, 5 In the current study, we found that overall accuracy rate of endoscopic biopsy calculated for all patients was 99.06%. Tatsuta et al calculated the accuracy of endoscopic biopsy in diagnosis of malignancies of the upper GI tract and gave 97.4% as the result. 5 Like our result, this study clearly indicate that endoscopic biopsy is a very reliable method for the early diagnosis of gastric cancer.
This study found 10 (0.94%) false-negative diagnoses of malignancy among 1,068 patients who underwent UGI endoscopy. There are multiple factors that may caused misdiagnosis of gastric cancer. In a study conducted by Pailoor et al, 2 out of 23 (9.7%) endoscopically suspected gastric malignancy were proven to be chronic gastritis and 8 out of 14 (57.12%) benign gastric ulcer found on endoscopy were adenocarcinoma when examined by pathologists. 12 The difference between endoscopy and histology Aslan et al in a case report of an UGI malignancy stated that large lesion size and the small sample taken via the endoscopic biopsy forceps may result in inaccurate diagnosis. 13 Other reason stated by Tatsuta et al that may caused low accuracy in diagnosing gastric malignancy was that the cancer tissues were usually covered by normal gastric mucous, and when ulcerations may serve as the most suitable target sites for biopsy. 5 Medication used for relieving dyspeptic symptoms may also cause false-negative diagnosis. Most patients in this study had proton pump inhibitors prior to endoscopy. Use of the powerful acid suppressing agents such as proton pump inhibitors and H2 receptor antagonists can mask endoscopic signs of early gastric cancer. This condition resulted from mucosal healing of lesion, especially in early gastric cancer. The improved mucosal lesion may also covered malignant tissue when biopsied. 14 In order to reduce false-negative diagnosis, Amin et al recommended to take multiple biopsies and for gastric ulcers these should be obtained from both the rim and base. 15 Recommendations on the optimum number of biopsies differ but some studies noted that the greater the biopsy number performed, the more accurate the diagnosis of UGI malignancy. 15, 16, 17 yielded a correct diagnosis in 70% of gastric carcinomas while a total of seven biopsy specimens yielded greater than 98%. 16 Other study suggested at least 6 biopsy specimens should be taken from suspected malignant gastric lesions to obtain diagnostic accuracy of 100%. 17, 18 However, multiple biopsies posed some issues need to be remembered, such as high tendency to post procedure bleeding, increased time taken on endoscopy, and extra hour for examination by pathologists. 19 Some techniques may also be used in obtaining malignant tissue, such as brushing, aspiration, suction, salvage, and imprint cytology to improve the diagnostic yield of biopsy specimens in UGI malignancies. 12 gastric malignancy, especially those located in sub biopsy samples were only obtained by using forceps and only limited to the covering mucous. Kojima et al used endoscopic resection for lesions originating in the muscularis mucosa or submucous. 20 This study has several implications. First, UGI endoscopy still remain important modality in diagnosing malignancy and therefore need to be distributed throughout every district hospital as screening tool. Second, several important factors such as evaluation of the clinical data, supporting laboratory or imaging data, experience in choosing appropriate biopsy number and site, proper processing of biopsy tissue and meticulous report by the histopathologist for interpretation of endoscopic biopsies may be noticed in establishing diagnosis of gastric malignancy. Diagnosis histopathology, therefore follow-up endoscopy may be needed. Endoscopy is an informative tool with malignancy.
